Furthermore, the anti-epidermal growth factor receptor (EGFR) mAb cetuximab, used for treatment of metastatic colorectal cancer, improves the overall survival of patients with wild-type K-ras tumors [2,3]. Here, EGFR is linked to metastatic colorectal cancer.